Antiviral treatment for hepatitis B virus (HBV) is associated with a lower risk of hepatocellular carcinoma, researchers reported. In a retrospective look at a cohort of people with chronic HBV, about three patients in 100 developed hepatocellular carcinoma over 5 years of follow-up, according to David Nerenz, PhD, of Henry Ford Health System in Detroit, and colleagues.

READ FULL ARTICLE Curated publisher From Medical Page Today